To corroborate that SMAD2 mediates the role of miR-190 in TGF-β-induced responses in breast cancer cells, we transfected HA-SMAD2 plasmid into MCF10A cells in addition to TGF-β stimulation and miR-190 overexpression. Here, TGFB1 is linked to breast carcinoma.